- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
7
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
7 companies
Krystal Biotech
Market Cap: US$9.6b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$325.78
7D
-10.3%
1Y
139.5%
Bruker
Market Cap: US$7.7b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
BRKR
US$52.47
7D
-15.0%
1Y
71.1%
Veracyte
Market Cap: US$3.6b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$46.41
7D
-16.6%
1Y
85.6%
Vera Therapeutics
Market Cap: US$2.3b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
VERA
US$29.95
7D
-10.1%
1Y
45.1%
Tyra Biosciences
Market Cap: US$1.9b
A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.
TYRA
US$25.71
7D
-17.4%
1Y
133.1%
Faeth Therapeutics
Market Cap: US$657.4m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
FTH
US$24.59
7D
-15.0%
1Y
217.3%
Fortress Biotech
Market Cap: US$90.4m
Operates as a biopharmaceutical company in the United States and internationally.
FBIO
US$2.79
7D
-16.7%
1Y
48.4%